LRP2 and breast carcinoma: Interestingly, we observed high LRP2 expression in non-CSC from cancer cell, PDX, and patients tumor as well as in TNBC patients (n = 162) compared to CSC cells and luminal type breast cancer patients (n = 218) from the same groups (Supplementary Fig. 12F, G).